Cargando…
Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
Immunosuppressive drugs can alleviate debilitating symptoms of autoimmune diseases, but, by the same token, excessive immune suppression can result in an increased risk of infection. Despite the dangers of a compromised immune system, clear definitions of what constitutes excessive suppression remai...
Autores principales: | Kareva, Irina, Zutshi, Anup, Mateo, Cristina Vazquez, Papasouliotis, Orestis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478771/ https://www.ncbi.nlm.nih.gov/pubmed/34328632 http://dx.doi.org/10.1007/s13318-021-00706-z |
Ejemplares similares
-
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
por: Kareva, Irina, et al.
Publicado: (2021) -
Mathematical modeling of SARS-CoV-2 viral dynamics and treatment with monoclonal antibodies
por: Kareva, Irina, et al.
Publicado: (2022) -
Bispecific antibodies: A guide to model informed drug discovery and development
por: Kareva, Irina, et al.
Publicado: (2021) -
Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19
por: Soofi, Moslem, et al.
Publicado: (2020) -
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021)